Füllhase C, Hakenberg O. 2015. New concepts for the treatment of male lower urinary tract symptoms. Curr Opin Urol;25(1):19-26.
Perera M, Roberts MJ, Doi SA, Bolton D. 2014. Prostatic urethral lift improves urinary symptoms and flow while preserving sexual function for men with benign prostatic hyperplasia: A systematic review and meta-analysis.
Eur Urol. 2014 Nov 15. pii: S0302-2838(14)01120-8.
Silva J, Silva CM, Cruz F. 2014. Current medical treatment of lower urinary tract symptoms/BPH: do we have a standard? Curr Opin Urol. 2014 Jan;24(1):21-8.
Zhang LT, Park JK. 2015. Are phosphodiesterase type 5 inhibitors effective for the management of lower urinary symptoms suggestive of benign prostatic hyperplasia? World J Nephrol. 2015 Feb 6;4(1):138-47.
Ahmed AF. Sonographic Parameters Predicting the Outcome of Patients with Lower Urinary Tract Symptoms/Benign Prostatic Hyperplasia Treated with Alpha1-Adrenoreceptor Antagonist. Urology. 2015 Nov 19.
Al-Khalil S, Boothe D, Durdin T, et al. Interactions between benign prostatic hyperplasia (BPH) and prostate cancer in large prostates: a retrospective data review. Int Urol Nephrol. 2015 Nov 21.
Chung SD, Tzeng YM, Lin HC, et al. Healthcare utilization and costs in patients with benign prostatic hyperplasia: a population-based study. Asian J Androl. 2015 Nov 20.